Operating Expenses Summary of PharmAust Limited

PharmAust Limited's latest annual operating expenses in 2024 was 6.65 Million AUD , up 147.19% from previous year.
PharmAust Limited's latest quarterly operating expenses in 2024 FY was 6.65 Million AUD , up 147.19% from previous quarter.
PharmAust Limited reported a annual operating expenses of 2.69 Million AUD in annual operating expenses 2023, up 6.63% from previous year.
PharmAust Limited reported a annual operating expenses of 2.52 Million AUD in annual operating expenses 2022, up 25.15% from previous year.
PharmAust Limited reported a quarterly operating expenses of 2.46 Million AUD for 2024 Q2, down 0.0% from previous quarter.
PharmAust Limited reported a quarterly operating expenses of 4.19 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of PharmAust Limited (2024 - 2001)

Historical Annual Operating Expenses of PharmAust Limited (2024 - 2001)

Year	Operating Expenses	Operating Expenses Growth
2024	6.65 Million AUD	147.19%
2023	2.69 Million AUD	6.63%
2022	2.52 Million AUD	25.15%
2021	2.01 Million AUD	15.52%
2020	1.74 Million AUD	-68.43%
2019	5.53 Million AUD	0.63%
2018	5.49 Million AUD	28.59%
2017	4.27 Million AUD	-33.25%
2016	6.4 Million AUD	55.01%
2015	4.13 Million AUD	33.36%
2014	3.09 Million AUD	47.2%
2013	2.1 Million AUD	-62.85%
2012	5.66 Million AUD	152.07%
2011	2.24 Million AUD	8.89%
2010	2.06 Million AUD	-5.45%
2009	2.18 Million AUD	-53.01%
2008	4.64 Million AUD	-55.6%
2007	10.47 Million AUD	38.12%
2006	7.58 Million AUD	96.34%
2005	3.86 Million AUD	188.71%
2004	1.33 Million AUD	-36.21%
2003	2.09 Million AUD	262.65%
2002	578 Thousand AUD	130.58%
2001	250.67 Thousand AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 FY	6.65 Million AUD	147.19%
2024 Q2	2.46 Million AUD	0.0%
2024 Q4	4.19 Million AUD	0.0%
2023 Q4	1.51 Million AUD	0.0%
2023 FY	2.69 Million AUD	6.63%
2023 Q2	1.18 Million AUD	0.0%
2022 FY	2.52 Million AUD	25.15%
2022 Q4	1.52 Million AUD	0.0%
2022 Q2	1.02 Million AUD	0.0%
2021 FY	2.01 Million AUD	15.52%
2021 Q2	997.12 Thousand AUD	0.0%
2021 Q4	1.02 Million AUD	0.0%
2020 Q2	1.22 Million AUD	0.0%
2020 FY	1.74 Million AUD	-68.43%
2020 Q4	522.7 Thousand AUD	0.0%
2019 FY	5.53 Million AUD	0.63%
2019 Q2	2.41 Million AUD	0.0%
2019 Q4	1.53 Million AUD	0.0%
2018 Q2	3.01 Million AUD	0.0%
2018 FY	5.49 Million AUD	28.59%
2018 Q4	2.48 Million AUD	0.0%
2017 Q4	2.41 Million AUD	0.0%
2017 Q2	1.85 Million AUD	0.0%
2017 FY	4.27 Million AUD	-33.25%
2016 Q4	4.09 Million AUD	0.0%
2016 Q2	2.31 Million AUD	0.0%
2016 FY	6.4 Million AUD	55.01%
2015 FY	4.13 Million AUD	33.36%
2015 Q4	2.19 Million AUD	0.0%
2015 Q2	1.94 Million AUD	0.0%
2014 Q2	1.59 Million AUD	146840.69%
2014 Q1	1087.50 AUD	0.0%
2014 FY	3.09 Million AUD	47.2%
2014 Q4	1.5 Million AUD	0.0%
2013 Q2	1.16 Million AUD	37.85%
2013 Q3	1087.50 AUD	-99.91%
2013 Q1	843.58 Thousand AUD	0.0%
2013 Q4	1087.50 AUD	0.0%
2013 FY	2.1 Million AUD	-62.85%
2012 FY	5.66 Million AUD	152.07%
2012 Q4	843.58 Thousand AUD	0.0%
2012 Q3	843.58 Thousand AUD	0.0%
2012 Q2	843.58 Thousand AUD	-32.54%
2012 Q1	1.25 Million AUD	0.0%
2011 FY	2.24 Million AUD	8.89%
2011 Q4	1.25 Million AUD	0.0%
2011 Q1	516.28 Thousand AUD	0.0%
2011 Q2	1.25 Million AUD	142.22%
2011 Q3	1.25 Million AUD	0.0%
2010 Q2	516.28 Thousand AUD	874.42%
2010 FY	2.06 Million AUD	-5.45%
2010 Q1	52.98 Thousand AUD	0.0%
2010 Q4	516.28 Thousand AUD	0.0%
2010 Q3	516.28 Thousand AUD	0.0%
2009 FY	2.18 Million AUD	-53.01%
2009 Q1	568.08 Thousand AUD	0.0%
2009 Q2	52.98 Thousand AUD	-90.67%
2009 Q3	52.98 Thousand AUD	0.0%
2009 Q4	52.98 Thousand AUD	0.0%
2008 Q2	568.08 Thousand AUD	361.47%
2008 Q3	568.08 Thousand AUD	0.0%
2008 Q4	568.08 Thousand AUD	0.0%
2008 FY	4.64 Million AUD	-55.6%
2008 Q1	123.1 Thousand AUD	0.0%
2007 Q1	623.19 Thousand AUD	0.0%
2007 Q4	123.1 Thousand AUD	0.0%
2007 Q3	123.1 Thousand AUD	0.0%
2007 FY	10.47 Million AUD	38.12%
2007 Q2	123.1 Thousand AUD	-80.25%
2006 FY	7.58 Million AUD	96.34%
2006 Q2	623.19 Thousand AUD	1848.14%
2006 Q3	623.19 Thousand AUD	0.0%
2006 Q4	623.19 Thousand AUD	0.0%
2006 Q1	31.98 Thousand AUD	0.0%
2005 Q3	31.98 Thousand AUD	0.0%
2005 Q2	31.98 Thousand AUD	-89.37%
2005 Q1	301 Thousand AUD	0.0%
2005 Q4	31.98 Thousand AUD	0.0%
2005 FY	3.86 Million AUD	188.71%
2004 Q3	301 Thousand AUD	0.0%
2004 Q1	562.52 Thousand AUD	0.0%
2004 FY	1.33 Million AUD	-36.21%
2004 Q4	301 Thousand AUD	0.0%
2004 Q2	301 Thousand AUD	-46.49%
2003 Q1	276.01 Thousand AUD	0.0%
2003 FY	2.09 Million AUD	262.65%
2003 Q2	562.52 Thousand AUD	103.8%
2003 Q4	562.52 Thousand AUD	0.0%
2003 Q3	562.52 Thousand AUD	0.0%
2002 Q3	276.01 Thousand AUD	0.0%
2002 FY	578 Thousand AUD	130.58%
2002 Q4	276.01 Thousand AUD	0.0%
2002 Q2	276.01 Thousand AUD	540.44%
2002 Q1	-62.66 Thousand AUD	0.0%
2001 Q3	-62.66 Thousand AUD	0.0%
2001 Q4	-62.66 Thousand AUD	0.0%
2001 Q2	-62.66 Thousand AUD	0.0%
2001 FY	250.67 Thousand AUD	0.0%

Peer Operating Expenses Comparison of PharmAust Limited

Name	Operating Expenses	Operating Expenses Difference
EZZ Life Science Holdings Limited	39.57 Million AUD	83.179%
Anatara Lifesciences Ltd	710.21 Thousand AUD	-837.318%
Zelira Therapeutics Limited	5.94 Million AUD	-11.91%
Biome Australia Limited	7.91 Million AUD	15.854%
Patrys Limited	4.93 Million AUD	-34.94%
Orthocell Limited	15.36 Million AUD	56.687%
Imugene Limited	135.09 Million AUD	95.072%
Noxopharm Limited	7 Million AUD	4.903%
PYC Therapeutics Limited	60.91 Million AUD	89.072%
Chimeric Therapeutics Limited	19.76 Million AUD	66.323%
Prescient Therapeutics Limited	10.89 Million AUD	38.92%
Proteomics International Laboratories Limited	892.14 Thousand AUD	-646.18%
Cynata Therapeutics Limited	11.12 Million AUD	40.154%
CSL Limited	7.56 Billion AUD	99.912%
Arovella Therapeutics Limited	10.78 Million AUD	38.277%
Bio-Gene Technology Limited	2.76 Million AUD	-141.107%
Clinuvel Pharmaceuticals Limited	31.29 Million AUD	78.73%
Starpharma Holdings Limited	22.81 Million AUD	70.823%
Nanollose Limited	12.5 Thousand AUD	-53151.652%
Memphasys Limited	3.67 Million AUD	-80.976%
Invex Therapeutics Ltd	3.34 Million AUD	-98.961%
NeuroScientific Biopharmaceuticals Limited	1.96 Million AUD	-238.74%
Amplia Therapeutics Limited	8.43 Million AUD	21.086%
Botanix Pharmaceuticals Limited	601.82 Thousand AUD	-1006.143%
Island Pharmaceuticals Limited	4.12 Million AUD	-61.368%
Race Oncology Limited	14.77 Million AUD	54.93%
Nyrada Inc.	4.55 Million AUD	-46.141%
Telix Pharmaceuticals Limited	269.26 Million AUD	97.528%
Dimerix Limited	25.64 Million AUD	74.04%
Immutep Limited	42.87 Million AUD	84.474%
Clarity Pharmaceuticals Ltd	56.3 Million AUD	88.177%
Alterity Therapeutics Limited	23.4 Million AUD	71.559%
BTC Health Limited	-1.03 Million AUD	740.756%
Acrux Limited	8.55 Million AUD	22.14%
Neuren Pharmaceuticals Limited	32.69 Million AUD	79.64%
Biotron Limited	5.11 Million AUD	-30.257%
Tissue Repair Ltd	6.66 Million AUD	0.147%
AdAlta Limited	6.76 Million AUD	1.662%
Radiopharm Theranostics Limited	299.22 Thousand AUD	-2124.721%
Hexima Limited	1 Million AUD	-559.925%
AnteoTech Limited	12.18 Million AUD	45.376%
Paradigm Biopharmaceuticals Limited	65.1 Million AUD	89.775%
Recce Pharmaceuticals Ltd	21.68 Million AUD	69.301%
Avecho Biotechnology Limited	4.54 Million AUD	-46.456%
Actinogen Medical Limited	22.77 Million AUD	70.765%
Immuron Limited	9.13 Million AUD	27.15%
Argenica Therapeutics Limited	8.26 Million AUD	19.496%

Global Stocks Search

PharmAust Limited (PAA.AX)

Operating Expenses Summary of PharmAust Limited

Annual Operating Expenses Chart of PharmAust Limited (2024 - 2001)

Historical Annual Operating Expenses of PharmAust Limited (2024 - 2001)

Peer Operating Expenses Comparison of PharmAust Limited